Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors

W. Piacibello, D. Ferrero, F. Sanavio, R. Badoni, A. Stacchini, A. Severino, M. Aglietta

Research output: Contribution to journalArticle

Abstract

Human early and late granulocyte-monocyte progenitors (granulocyte-macrophage colony-forming units, CFU-GM), depleted of accessory cells, were physically separated using an antimyeloid monoclonal antibody (DS1.1). They were separately cultured at optimal growth conditions and tested for responsiveness to prostaglandin E2 (PGE2), recombinant tumor necrosis factor alpha (TNFα), and transforming growth factor beta-1 (TGFβ1). Late (DS1.1+) CFU-GM displayed the highest sensitivity to PGE2 and TNFα, the first significant inhibition being evident at 10-9M PGE2 and 1 U/ml TNFα. Conversely, their growth was stimulated (211%-217%) by 0.25-2.5 ng/ml TGFβ1. Early (DS1.1-) marrow CFU-GM evidenced a lower sensitivity to PGE2 and TNFα. Their growth, however, was inhibited by 0.25-2.5 ng/ml TGFβ1. Early CFU-GM constitute the totality of peripheral blood myeloid progenitors. Cord blood CFU-GM were also demonstrated here to be entirely DS1.1-. Both adult and cord blood CFU-GM displayed the highest resistance to PGE2 and TNFα. By contrast, they showed the maximum sensitivity to growth inhibition by TGFβ1, active at 0.025-0.25 ng/ml. For the first time, therefore, highly purified subsets of human CFU-GM were separated that displayed a different responsiveness to well-defined growth-regulatory molecules. Our results indicate that TGFβ1 has a dual activity; it is inhibitory on early and stimulatory on late CFU-GM, whereas PGE2 and TNFα preferentially inhibit late CFU-GM growth.

Original languageEnglish
Pages (from-to)1084-1089
Number of pages6
JournalExperimental Hematology
Volume19
Issue number11
Publication statusPublished - 1991

Fingerprint

Growth Inhibitors
Granulocyte-Macrophage Progenitor Cells
Fetal Blood
Bone Marrow
Dinoprostone
Transforming Growth Factor beta
Tumor Necrosis Factor-alpha
Growth
Granulocyte Precursor Cells
Monocytes
Monoclonal Antibodies

Keywords

  • Cytokines
  • Inhibitors
  • Myelopoiesis
  • Regulation

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. / Piacibello, W.; Ferrero, D.; Sanavio, F.; Badoni, R.; Stacchini, A.; Severino, A.; Aglietta, M.

In: Experimental Hematology, Vol. 19, No. 11, 1991, p. 1084-1089.

Research output: Contribution to journalArticle

Piacibello, W, Ferrero, D, Sanavio, F, Badoni, R, Stacchini, A, Severino, A & Aglietta, M 1991, 'Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors', Experimental Hematology, vol. 19, no. 11, pp. 1084-1089.
Piacibello, W. ; Ferrero, D. ; Sanavio, F. ; Badoni, R. ; Stacchini, A. ; Severino, A. ; Aglietta, M. / Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. In: Experimental Hematology. 1991 ; Vol. 19, No. 11. pp. 1084-1089.
@article{145fc18aa6b048b580cb33ec3dc8cb19,
title = "Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors",
abstract = "Human early and late granulocyte-monocyte progenitors (granulocyte-macrophage colony-forming units, CFU-GM), depleted of accessory cells, were physically separated using an antimyeloid monoclonal antibody (DS1.1). They were separately cultured at optimal growth conditions and tested for responsiveness to prostaglandin E2 (PGE2), recombinant tumor necrosis factor alpha (TNFα), and transforming growth factor beta-1 (TGFβ1). Late (DS1.1+) CFU-GM displayed the highest sensitivity to PGE2 and TNFα, the first significant inhibition being evident at 10-9M PGE2 and 1 U/ml TNFα. Conversely, their growth was stimulated (211{\%}-217{\%}) by 0.25-2.5 ng/ml TGFβ1. Early (DS1.1-) marrow CFU-GM evidenced a lower sensitivity to PGE2 and TNFα. Their growth, however, was inhibited by 0.25-2.5 ng/ml TGFβ1. Early CFU-GM constitute the totality of peripheral blood myeloid progenitors. Cord blood CFU-GM were also demonstrated here to be entirely DS1.1-. Both adult and cord blood CFU-GM displayed the highest resistance to PGE2 and TNFα. By contrast, they showed the maximum sensitivity to growth inhibition by TGFβ1, active at 0.025-0.25 ng/ml. For the first time, therefore, highly purified subsets of human CFU-GM were separated that displayed a different responsiveness to well-defined growth-regulatory molecules. Our results indicate that TGFβ1 has a dual activity; it is inhibitory on early and stimulatory on late CFU-GM, whereas PGE2 and TNFα preferentially inhibit late CFU-GM growth.",
keywords = "Cytokines, Inhibitors, Myelopoiesis, Regulation",
author = "W. Piacibello and D. Ferrero and F. Sanavio and R. Badoni and A. Stacchini and A. Severino and M. Aglietta",
year = "1991",
language = "English",
volume = "19",
pages = "1084--1089",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors

AU - Piacibello, W.

AU - Ferrero, D.

AU - Sanavio, F.

AU - Badoni, R.

AU - Stacchini, A.

AU - Severino, A.

AU - Aglietta, M.

PY - 1991

Y1 - 1991

N2 - Human early and late granulocyte-monocyte progenitors (granulocyte-macrophage colony-forming units, CFU-GM), depleted of accessory cells, were physically separated using an antimyeloid monoclonal antibody (DS1.1). They were separately cultured at optimal growth conditions and tested for responsiveness to prostaglandin E2 (PGE2), recombinant tumor necrosis factor alpha (TNFα), and transforming growth factor beta-1 (TGFβ1). Late (DS1.1+) CFU-GM displayed the highest sensitivity to PGE2 and TNFα, the first significant inhibition being evident at 10-9M PGE2 and 1 U/ml TNFα. Conversely, their growth was stimulated (211%-217%) by 0.25-2.5 ng/ml TGFβ1. Early (DS1.1-) marrow CFU-GM evidenced a lower sensitivity to PGE2 and TNFα. Their growth, however, was inhibited by 0.25-2.5 ng/ml TGFβ1. Early CFU-GM constitute the totality of peripheral blood myeloid progenitors. Cord blood CFU-GM were also demonstrated here to be entirely DS1.1-. Both adult and cord blood CFU-GM displayed the highest resistance to PGE2 and TNFα. By contrast, they showed the maximum sensitivity to growth inhibition by TGFβ1, active at 0.025-0.25 ng/ml. For the first time, therefore, highly purified subsets of human CFU-GM were separated that displayed a different responsiveness to well-defined growth-regulatory molecules. Our results indicate that TGFβ1 has a dual activity; it is inhibitory on early and stimulatory on late CFU-GM, whereas PGE2 and TNFα preferentially inhibit late CFU-GM growth.

AB - Human early and late granulocyte-monocyte progenitors (granulocyte-macrophage colony-forming units, CFU-GM), depleted of accessory cells, were physically separated using an antimyeloid monoclonal antibody (DS1.1). They were separately cultured at optimal growth conditions and tested for responsiveness to prostaglandin E2 (PGE2), recombinant tumor necrosis factor alpha (TNFα), and transforming growth factor beta-1 (TGFβ1). Late (DS1.1+) CFU-GM displayed the highest sensitivity to PGE2 and TNFα, the first significant inhibition being evident at 10-9M PGE2 and 1 U/ml TNFα. Conversely, their growth was stimulated (211%-217%) by 0.25-2.5 ng/ml TGFβ1. Early (DS1.1-) marrow CFU-GM evidenced a lower sensitivity to PGE2 and TNFα. Their growth, however, was inhibited by 0.25-2.5 ng/ml TGFβ1. Early CFU-GM constitute the totality of peripheral blood myeloid progenitors. Cord blood CFU-GM were also demonstrated here to be entirely DS1.1-. Both adult and cord blood CFU-GM displayed the highest resistance to PGE2 and TNFα. By contrast, they showed the maximum sensitivity to growth inhibition by TGFβ1, active at 0.025-0.25 ng/ml. For the first time, therefore, highly purified subsets of human CFU-GM were separated that displayed a different responsiveness to well-defined growth-regulatory molecules. Our results indicate that TGFβ1 has a dual activity; it is inhibitory on early and stimulatory on late CFU-GM, whereas PGE2 and TNFα preferentially inhibit late CFU-GM growth.

KW - Cytokines

KW - Inhibitors

KW - Myelopoiesis

KW - Regulation

UR - http://www.scopus.com/inward/record.url?scp=0026001234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026001234&partnerID=8YFLogxK

M3 - Article

C2 - 1752317

AN - SCOPUS:0026001234

VL - 19

SP - 1084

EP - 1089

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 11

ER -